Alpha IVF Group Berhad (KLSE:ALPHA)

Malaysia · Delayed Price · Currency is MYR

0.2450

+0.0100 (4.26%)

At close: Sep 18, 2026

Market Cap	1.16B -20.4%
Revenue (ttm)	198.59M +12.3%
Net Income	53.64M -6.6%
EPS	0.01 -6.4%
Shares Out	4.84B
PE Ratio	21.73
Forward PE	17.78
Dividend	0.01 (4.90%)
Ex-Dividend Date	Sep 29, 2026

Volume	4,251,000
Open	0.2400
Previous Close	0.2350
Day's Range	0.2400 - 0.2450
52-Week Range	0.2350 - 0.3450
Beta	0.09
Analysts	Strong Buy
Price Target	0.33 (+34.69%)
Earnings Date	Oct 29, 2026

About Alpha IVF Group Berhad

Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation op... [Read more]

Industry Offices and Clinics of Doctors of Medicine

Founded 2011

Employees 198

Stock Exchange Bursa Malaysia

Ticker Symbol ALPHA

Full Company Profile

Financial Performance

In fiscal year 2026, Alpha IVF Group Berhad's revenue was 198.59 million, an increase of 12.30% compared to the previous year's 176.84 million. Earnings were 53.64 million, a decrease of -6.65%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for ALPHA stock is "Strong Buy." The 12-month stock price target is RM 0.33, which is an increase of 34.69% from the latest price.

Price Target

RM 0.33

(34.69% upside)

Analyst Consensus: Strong Buy

Stock Forecasts